Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine

Clinical trial NCT00454987 · COMPLETED

Trial details

NCT number: NCT00454987
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Haemophilus Influenzae Type b Neisseria Meningitidis Neisseria Meningitidis-Haemophilus Influenzae Type b Vaccine

Start date: 2007-05-16
Primary completion: 2007-10-12
Enrollment: 288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.